To provide quality care and support professional development, all Rutgers Juvenile Justice, all Rutgers Juvenile Justice and Youth Development Certificate Program courses have been planned and implemented by UBHC and Rutgers Biomedical Health Sciences. Rutgers Biomedical Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.
Rutgers Biomedical and Health Sciences is approved by the American Psychological Association to sponsor continuing education for psychologists. This activity will offer 6.0 CE credits for psychologists.
Rutgers University Behavioral Health Care has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6198. Programs that do not qualify for NBCC credit are clearly identified. Rutgers University Behavioral Health Care is solely responsible for all aspects of the program. (6.0 Clock Hours)
This program is approved for social work continuing education hours by Rutgers University Behavioral Health Care in accordance with New Jersey administrative code 13:44G-6.4 and recognized by The New Jersey Board of Social Work Examiners (NJBSWE). This program is approved for 6.0 clinical social work continuing education hours. This is only for NJ social workers.
As a Jointly Accredited Organization, Rutgers University Behavioral Health Care is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Rutgers University Behavioral Health Care maintains responsibility for this course. Social workers completing this course receive 6.0 clinical continuing education credits.
ASWB ACE is eligible for national CE Credits. Please refer to: https://www.aswb.org/licenses/ace-approved-continuing-education/states-and-provinces-that-accept-ace/
Continuing education content for this course has been submitted to the Certification Board Inc. of New Jersey for LAC/LPC; LCADC/CADC; and MFT/LMFT.
Continuing education content for this course has been submitted to the Certification Board Inc. of New Jersey for LAC/LPC; LCADC/CADC; and MFT/LMFT.
Continuing education content for this course has been submitted to the Certification Board Inc. of New Jersey for LAC/LPC; LCADC/CADC; and MFT/LMFT.
In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, RBHS will resolve all potential and real conflicts of interest through content review by non-conflicted, qualified reviewers.
In accordance with the disclosure policies of Rutgers UBHC to conform with Joint Accreditation requirements and FDA guidelines, individuals in a position to control the content of this education activity are required to disclose to the activity participants: the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 24 months; and the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device that is not yet approved.
The following faculty have no relevant financial relationships to disclose:
Laura Burns, LCSW; Stephanie Marcello, PhD; and Therese Saulo Reseska, LPC, LCADC have no relevant financial relationships to disclose.
The following planners have no relevant financial relationships to disclose: Tameka Chatman, MA, LCADC, SAP
Faculty are required to disclose discussion of off-label/investigational uses of commercial products/devices in their presentation. These disclosures will be made to the audience at the time of the activity.
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices, Rutgers University RBHS.
It should be noted that the recommendations made herein with regards to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. Any drug references, selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products or procedures before using them in clinical practice.
Copyright © 2023 Rutgers Biomedical and Health Sciences and UBHC. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or any information storage and retrieval systems, without written permission from the Rutgers.
Questions? Please direct content, CE-related questions or concerns to Rutgers UBHC (CCE) at cce@ubhc.rutgers.edu.